Skip to main content

Patient Support Line 1-800-282-7630, Monday – Friday: 9 AM – 5 PM ET

KISQALI is proven to help premenopausal and postmenopausal women, and men, with HR+, HER2- metastatic breast cancer.

Ask your doctor for KISQALI ribociclib 200 mg tablets
LIVING LONGER WITH MBC

Understanding Overall Survival

Learn helpful information about how overall survival is different from progression-free survival.

SUPPORT MADE SIMPLE

Novartis Patient Support

Find support and other services to help throughout treatment.

Important Safety Information

What is the most important information I should know about KISQALI ?

KISQALI may cause serious side effects, including:

Lung problems. KISQALI may cause severe or life-threatening inflammation of the lungs during treatment that may lead to death. Tell your health care provider right away if you have any new or...

Indications

KISQALI is a prescription medicine used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has gotten worse or has spread to other parts of the body (metastatic), in combination with:

  • an aromatase inhibitor as the first endocrine-based therapy; or...
Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USE